| Dr Brian Coudray Sole, PHARMD | |
|
3179 Hacienda Dr, Concord, CA 94519-2239 | |
| (943) 437-4743 | |
| Not Available |
| Full Name | Dr Brian Coudray Sole |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3179 Hacienda Dr, Concord, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043560709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH67461 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Coudray Sole, PHARMD 3179 Hacienda Dr, Concord, CA 94519-2239 Ph: (943) 437-4743 | Dr Brian Coudray Sole, PHARMD 3179 Hacienda Dr, Concord, CA 94519-2239 Ph: (943) 437-4743 |
News Archive
It's no secret that low-birth-weight babies face significantly greater risks for certain health problems early on, such as respiratory distress or infection. Now, a new study from researchers at the University of Florida and Northwestern University shows that lower weights at birth also have an adverse effect on children's performance in school, which is likely due to the early health struggles small babies often face.
Efforts to treat myotonic dystrophy type 1, the most common form of muscular dystrophy, are in their infancy. In a new study, researchers report they have added new capabilities to an experimental drug agent that previously defeated only one of DM1's many modes of action. Their retooled compounds interrupt the disease's pathology in three ways.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for 2010 exceeded $400 million, beating previously issued guidance of $360 million to $385 million.
Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.
A recent study conducted at Nathan S. Kline Institute for Psychiatric Research and NYU Langone Medical Center implicates a new culprit in Alzheimer's disease development. The research reveals that ßCTF - the precursor of the amyloid beta (Aß) peptide - acts at the earliest stage of Alzheimer's to initiate a range of abnormalities leading to the loss of groups of neurons critical for memory formation.
› Verified 3 days ago
Ms. Colleen Marie Stagg, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-674-2130 | |
Marianne Lena Moussa, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5460 Concord Blvd Apt B5, Concord, CA 94521 Phone: 925-876-4145 | |
Paul Arthur Newton Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Willow Pass Rd, Concord, CA 94519 Phone: 925-689-0895 | |
Kamaldeep Singh Sandhu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2540 East St, Attn: Inpatient Pharmacy, Concord, CA 94520 Phone: 925-674-2130 | |
Dr. Jerry Michael Horner, PHARM.D, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-682-8200 | |
Dr. Danh H Vo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Concord Ave, Concord, CA 94520 Phone: 925-674-9477 Fax: 925-674-9258 |